OVERVIEW

The IAS–USA Annual Virtual Course Update: Emerging Challenges in HIV Medicine is organized by International Antiviral Society-USA (IAS-USA) and will be held on Dec 04, 2025.

Description:
This comprehensive half-day virtual course will explore emerging challenges in HIV medicine. This course will delve into difficult cases in antiretroviral therapy, including the implementation of long-acting drugs. The course will also address key issues in HIV prevention, such as postexposure prophylaxis (PEP) for sexual and occupational exposures, and the future of HIV vaccines in the context of emerging long-acting agents. Other key topics include updates on sexually transmitted infections (STIs), including the use of doxycycline postexposure prophylaxis (doxy-PEP), antimicrobial resistance trends, and national penicillin shortages, and highlights of recent data and guideline changes presented at major scientific conferences.

Learning Objectives
After participating in the activity, learners will be able to:

  • Implement the latest recommendations for initiating and changing antiretroviral therapy in clinical circumstances such as comorbid conditions, coinfections, pregnancy, and geriatric syndromes
  • Describe the most current data from recent scientific conferences, including research on new and investigational antiretroviral drugs
  • Describe best practices for PEP following sexual and occupational exposures, including differences in follow-up protocols and vaccination considerations
  • Assess the evolving role of HIV vaccines, including current research directions and the need for vaccines in the context of long-acting prevention strategies
  • Describe the latest evidence-based treatment guidelines for common STIs, including clinical implications and antimicrobial resistance trends

Preliminary Topics

  • Difficult cases in antiretroviral therapy
  • PEP for sexual and occupational (ie, healthcare worker) exposures
  • HIV vaccines in 2026 and beyond
  • Emerging issues in STIs, including doxy-PEP, antimicrobial resistance, and drug shortages
  • “In Case You Missed It” overview of recent conference data, guidelines, and publications.

KEY DATES

Event Start Date
04 Dec, 2025
Event Start Date
Event End Date
04 Dec, 2025
Event End Date
Credits

Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits

Nursing Credits
Educational Review Systems is an approved approver of continuing nursing education by the ASNA, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 4.0 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California (Provider # 14692), the state of Florida and the District of Columbia.

This program is approved for 4.0 hours of pharmacotherapy credit.

Pharmacy Credits
Accreditation Council for Pharmacy Education logo Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 4.0 contact hours (0.4 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.

  • 4 AMA PRA Category 1 Credits™
  • 4 MOC
  • 4 Hours
  • 0.4 CEU
  • 4 Contact Hours

    • TARGET AUDIENCE

    PhysicianNursingPharmacistPhysician AssistantResearchersNurse PractitionersFellows

    SPECIALITIES

    HIV AIDS Nurse
    Quick Linksfooter

    Copyrights © 2026 eMedEvents Corporation, All Rights Reserved